Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens? (Links to an external site)
Author: Ellen
International Alzheimer’s prevention trial in young adults begins (Links to an external site)
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise
Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site)
Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site)
Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site)
Seeking Alzheimer’s clues from few who escape genetic fate (Links to an external site)
Lifetime Achievement Award (Links to an external site)
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site)
FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site)
WashU, Eisai form drug discovery collaboration (Links to an external site)
